drugset / Trial / NCT02729935

Parecoxib for Treatment of Catheter Related Bladder Discomfort

NCT02729935

Phase 4 Completed 60 enrolled University Tunis El Manar
RandomizedParallel-groupTriple-blindPrevention

Summary

Catheter-related bladder discomfort (CRBD) is defined as an urge to void or discomfort in the supra-pubic region; reported postoperatively in patients who have had urinary catheterization intra-operatively. In the present study, the investigators evaluated Parecoxib (P) for preventing CRBD in patients undergoing catheterization after transurethral resection of bladder tumor (TURBT).

Timeline

Start
2016-03
Primary completion
2016-05
Completion
2016-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Parecoxib Small molecule 40 mg Intravenous

Indications

No indication recorded.